首页 > 最新文献

Case Reports in Medicine最新文献

英文 中文
Vaccine-Associated Disease Enhancement (VADE): Considerations in Postvaccination COVID-19. 疫苗相关疾病增强(VADE):对COVID-19疫苗接种后的考虑
IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-10-29 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9673453
Rahajeng N Tunjungputri, Erpryta Nurdia Tetrasiwi, Merlinda Veronica, Jacub Pandelaki, Fera Ibrahim, Erni Juwita Nelwan

Introduction: The COVID-19 pandemic has entered a new phase with the roll-out of several vaccines worldwide at an accelerated phase. The occurrence of a more severe presentation of COVID-19 after vaccination may affect policymakers' decision-making and vaccine uptake by the public. Vaccine-associated disease enhancement (VADE) is the modified presentation of infections in individuals after having received a prior vaccination. Currently, little is known about the potential of vaccine-associated disease enhancement (VADE) following COVID-19 immunization. Case Illustration. We herewith report two patients admitted with confirmed COVID-19 pneumonia with a history of CoronaVac vaccination. The first patient with a relatively milder course of the disease had received two doses of CoronaVac, whereas the second patient with a more progressive course of the disease received only one dose before developing symptoms and being admitted to the hospital. Our observations suggest that vaccination could act in boosting the inflammatory process and reveal the previously asymptomatic COVID-19 illness. Theoretically, vaccines could induce VADE, where only suboptimal, nonprotective titers of neutralizing antibodies were produced or proinflammatory T-helper type 2 response was induced. Secondly, enhanced respiratory disease (ERD) could manifest, where pulmonary symptoms are more severe due to peribronchial monocytic and eosinophilic infiltration. Understanding VADE is important for the decision-making by the public, clinicians, and policymakers and is warranted for successful vaccination uptake.

Conclusion: We report two cases of patients developing COVID-19 shortly after CoronaVac vaccination in which VADE is likely. We recommend that current vaccination strategies consider the measurement of neutralizing antibody titer as a guide in ensuring the safest strategy for mass immunization. Studies are needed to investigate the true incidence of VADE on vaccinated individuals as well as on how to differentiate between VADE and severe manifestations of COVID-19 that are unrelated to vaccination.

导言:COVID-19大流行已进入一个新阶段,全球正在加速推出几种疫苗。接种疫苗后出现更严重的COVID-19症状可能会影响决策者的决策和公众对疫苗的吸收。疫苗相关疾病增强(VADE)是个体在先前接种疫苗后感染的修改表现。目前,对COVID-19免疫接种后疫苗相关疾病增强(VADE)的潜力知之甚少。例说明。我们在此报告两例确诊为COVID-19肺炎并有冠状病毒疫苗接种史的住院患者。病程相对较轻的第一名患者接受了两剂CoronaVac,而病程较严重的第二名患者在出现症状并入院之前只接受了一剂。我们的观察结果表明,疫苗接种可以促进炎症过程,并揭示之前无症状的COVID-19疾病。理论上,疫苗可以诱导VADE,其中只产生次优的,非保护性滴度的中和抗体或诱导促炎性t辅助型2反应。其次,可能表现为增强呼吸系统疾病(ERD),由于支气管周围单核细胞和嗜酸性粒细胞浸润,肺部症状更为严重。了解VADE对于公众、临床医生和政策制定者的决策非常重要,并且是成功接种疫苗的保证。结论:我们报告了两例在冠状病毒疫苗接种后不久发生COVID-19的患者,其中有可能发生VADE。我们建议当前的疫苗接种策略考虑将中和抗体滴度的测量作为确保最安全的大规模免疫策略的指导。需要进行研究,以调查接种疫苗个体中VADE的真实发病率,以及如何区分VADE与与疫苗接种无关的COVID-19严重表现。
{"title":"Vaccine-Associated Disease Enhancement (VADE): Considerations in Postvaccination COVID-19.","authors":"Rahajeng N Tunjungputri,&nbsp;Erpryta Nurdia Tetrasiwi,&nbsp;Merlinda Veronica,&nbsp;Jacub Pandelaki,&nbsp;Fera Ibrahim,&nbsp;Erni Juwita Nelwan","doi":"10.1155/2021/9673453","DOIUrl":"https://doi.org/10.1155/2021/9673453","url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 pandemic has entered a new phase with the roll-out of several vaccines worldwide at an accelerated phase. The occurrence of a more severe presentation of COVID-19 after vaccination may affect policymakers' decision-making and vaccine uptake by the public. Vaccine-associated disease enhancement (VADE) is the modified presentation of infections in individuals after having received a prior vaccination. Currently, little is known about the potential of vaccine-associated disease enhancement (VADE) following COVID-19 immunization. <i>Case Illustration</i>. We herewith report two patients admitted with confirmed COVID-19 pneumonia with a history of CoronaVac vaccination. The first patient with a relatively milder course of the disease had received two doses of CoronaVac, whereas the second patient with a more progressive course of the disease received only one dose before developing symptoms and being admitted to the hospital. Our observations suggest that vaccination could act in boosting the inflammatory process and reveal the previously asymptomatic COVID-19 illness. Theoretically, vaccines could induce VADE, where only suboptimal, nonprotective titers of neutralizing antibodies were produced or proinflammatory T-helper type 2 response was induced. Secondly, enhanced respiratory disease (ERD) could manifest, where pulmonary symptoms are more severe due to peribronchial monocytic and eosinophilic infiltration. Understanding VADE is important for the decision-making by the public, clinicians, and policymakers and is warranted for successful vaccination uptake.</p><p><strong>Conclusion: </strong>We report two cases of patients developing COVID-19 shortly after CoronaVac vaccination in which VADE is likely. We recommend that current vaccination strategies consider the measurement of neutralizing antibody titer as a guide in ensuring the safest strategy for mass immunization. Studies are needed to investigate the true incidence of VADE on vaccinated individuals as well as on how to differentiate between VADE and severe manifestations of COVID-19 that are unrelated to vaccination.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"2021 ","pages":"9673453"},"PeriodicalIF":0.8,"publicationDate":"2021-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39597488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Primary Multifocal Recurrent Urinary Bladder Amyloidosis: A Rare Case Report from Syria. 原发性多灶性复发性膀胱淀粉样变性:叙利亚一例罕见病例报告。
IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-10-22 eCollection Date: 2021-01-01 DOI: 10.1155/2021/4476363
Leen Jamel Doya, Lama Doya, Khaled Al-Yousef, Ali Adib, Abedallah Al Shamali, Basel Al Deeb, Mohamad Kanan

Primary urinary bladder amyloidosis is a rare disorder of protein metabolism characterized by the extracellular deposition of fibrillin. To date, fewer than 200 cases have been reported in the literature. We herein present a case of 59-year-old female with primary multifocal recurrent urinary bladder amyloidosis. The patient was treated with a new method (laser therapy) mentioned for the first time in the literature. After 18 months of treatment, the patient has no complaints. Our case illustrates a new procedure in the treatment of primary multifocal bladder amyloidosis.

原发性膀胱淀粉样变性是一种罕见的以细胞外纤维蛋白沉积为特征的蛋白质代谢疾病。迄今为止,文献中报道的病例不到200例。我们在此报告一例59岁女性原发性多灶性复发性膀胱淀粉样变。患者采用文献中首次提到的新方法(激光治疗)进行治疗。治疗18个月后,患者无任何不适。我们的病例说明了一种治疗原发性多灶性膀胱淀粉样变的新方法。
{"title":"Primary Multifocal Recurrent Urinary Bladder Amyloidosis: A Rare Case Report from Syria.","authors":"Leen Jamel Doya,&nbsp;Lama Doya,&nbsp;Khaled Al-Yousef,&nbsp;Ali Adib,&nbsp;Abedallah Al Shamali,&nbsp;Basel Al Deeb,&nbsp;Mohamad Kanan","doi":"10.1155/2021/4476363","DOIUrl":"https://doi.org/10.1155/2021/4476363","url":null,"abstract":"<p><p>Primary urinary bladder amyloidosis is a rare disorder of protein metabolism characterized by the extracellular deposition of fibrillin. To date, fewer than 200 cases have been reported in the literature. We herein present a case of 59-year-old female with primary multifocal recurrent urinary bladder amyloidosis. The patient was treated with a new method (laser therapy) mentioned for the first time in the literature. After 18 months of treatment, the patient has no complaints. Our case illustrates a new procedure in the treatment of primary multifocal bladder amyloidosis.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"2021 ","pages":"4476363"},"PeriodicalIF":0.8,"publicationDate":"2021-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39579332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artery of Percheron in the Differential Diagnosis of Acute Altered Mental Status. 动脉在急性精神状态改变的鉴别诊断中的价值。
IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-10-22 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5583248
Maria Isabel Pérez Pan Art, Beatriz Sierra Bergua

Bilateral thalamic infarction is a rare entity (it occurs in 0.6% of ischemic strokes) and can be confused with other vascular etiologies such as basilar syndrome and deep cerebral venous thrombosis, as well as neoplasms, infections, or toxins. It is typically characterized by the triad of altered mental status, vertical gaze paralysis, and memory impairment, although their symptoms can be highly variable. We describe the case of a young man who came to the emergency department presenting diplopia, speech alteration, and decreased level of consciousness with frequent fluctuations. Baseline computerized tomography was normal, and because of the clinical findings, thrombolysis was performed. Subsequently made magnetic resonance showed a bilateral acute thalamic infarction caused by an obstruction of the Percheron artery. Although Percheron syndrome has been previously described in medical journals, our case is an unusual case in which we could perform an acute intravenous thrombolytic treatment. Besides, it is important for emergency physicians to enclose the Percheron syndrome in the differential diagnosis of coma in young people so that emergent treatments such as thrombolysis can be employed.

双侧丘脑梗死是一种罕见的实体(发生在缺血性卒中的0.6%),可与其他血管病因混淆,如基底动脉综合征和脑深静脉血栓形成,以及肿瘤、感染或毒素。它的典型特征是精神状态改变、垂直凝视瘫痪和记忆障碍,尽管它们的症状可能是高度可变的。我们描述的情况下,一个年轻人来到急诊科表现复视,语言改变,意识水平下降与频繁波动。基线计算机断层扫描正常,由于临床表现,进行了溶栓治疗。随后的磁共振显示双侧急性丘脑梗死由Percheron动脉阻塞引起。虽然Percheron综合征以前曾在医学期刊上描述过,但我们的病例是一个不寻常的病例,我们可以进行急性静脉溶栓治疗。此外,对于急诊医生来说,将Percheron综合征纳入年轻人昏迷的鉴别诊断是很重要的,这样就可以采用溶栓等紧急治疗。
{"title":"Artery of Percheron in the Differential Diagnosis of Acute Altered Mental Status.","authors":"Maria Isabel Pérez Pan Art,&nbsp;Beatriz Sierra Bergua","doi":"10.1155/2021/5583248","DOIUrl":"https://doi.org/10.1155/2021/5583248","url":null,"abstract":"<p><p>Bilateral thalamic infarction is a rare entity (it occurs in 0.6% of ischemic strokes) and can be confused with other vascular etiologies such as basilar syndrome and deep cerebral venous thrombosis, as well as neoplasms, infections, or toxins. It is typically characterized by the triad of altered mental status, vertical gaze paralysis, and memory impairment, although their symptoms can be highly variable. We describe the case of a young man who came to the emergency department presenting diplopia, speech alteration, and decreased level of consciousness with frequent fluctuations. Baseline computerized tomography was normal, and because of the clinical findings, thrombolysis was performed. Subsequently made magnetic resonance showed a bilateral acute thalamic infarction caused by an obstruction of the Percheron artery. Although Percheron syndrome has been previously described in medical journals, our case is an unusual case in which we could perform an acute intravenous thrombolytic treatment. Besides, it is important for emergency physicians to enclose the Percheron syndrome in the differential diagnosis of coma in young people so that emergent treatments such as thrombolysis can be employed.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"2021 ","pages":"5583248"},"PeriodicalIF":0.8,"publicationDate":"2021-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39579333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Valuable Role of Imaging Modalities in the Diagnosis of the Uncommon Presentations of COVID-19: An Educative Case Series. 影像学模式在诊断 COVID-19 罕见表现中的宝贵作用:教育性病例系列。
IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-10-13 eCollection Date: 2021-01-01 DOI: 10.1155/2021/7213627
Mohammadreza Khaleghi, Alireza Aziz-Ahari, Nahid Rezaeian, Sanaz Asadian, Amirsajjad Mounesi Sohi, Omid Motamedi, Shilan Azhdeh

The outbreak of coronavirus disease 2019 (COVID-19) in late 2019 rapidly turned into a global pandemic. Although the symptoms of COVID-19 are mainly respiratory ones, the infection is associated with a wide range of clinical signs and symptoms. The main imaging modality in COVID-19 is lung computed tomography (CT) scanning, but the diagnosis of the vast spectrum of complications needs the application of various imaging modalities. Owing to the novelty of the disease and its presentations, its complications-particularly uncommon ones-can be easily missed. In this study, we describe some uncommon presentations of COVID-19 diagnosed by various imaging modalities. The first case presented herein was a man with respiratory distress, who transpired to suffer from pneumothorax and pneumomediastinum in addition to the usual pneumonia of COVID-19. The second patient was a hospitalized COVID-19 case, whose clinical condition suddenly deteriorated with the development of abdominal symptoms diagnosed as mesenteric ischemia by abdominal CT angiography. The third patient was a case of cardiac involvement in the COVID-19 course, detected as myocarditis by cardiac magnetic resonance imaging (MRI). The fourth and fifth cases were COVID-19-associated encephalitis whose diagnoses were established by brain MRI. COVID-19 is a multisystem disorder with a wide range of complications such as pneumothorax, pneumomediastinum, mesenteric ischemia, myocarditis, and encephalitis. Prompt diagnosis with appropriate imaging modalities can lead to adequate treatment and better survival.

2019 年底爆发的冠状病毒病 2019(COVID-19)迅速演变成一场全球大流行。虽然 COVID-19 的症状主要是呼吸道症状,但感染后会出现多种临床症状和体征。COVID-19的主要影像学检查方式是肺部计算机断层扫描(CT),但对各种并发症的诊断需要应用多种影像学检查方式。由于该疾病及其表现形式的新颖性,其并发症(尤其是不常见的并发症)很容易被漏诊。在本研究中,我们描述了通过各种影像学模式诊断出的 COVID-19 的一些不常见表现。本文介绍的第一个病例是一名呼吸困难的男性患者,除了常见的 COVID-19 肺炎外,他还患有气胸和气胸。第二名患者是一名住院的 COVID-19 病例,其临床状况突然恶化,出现腹部症状,经腹部 CT 血管造影诊断为肠系膜缺血。第三例患者在 COVID-19 病程中累及心脏,经心脏磁共振成像(MRI)诊断为心肌炎。第四例和第五例病例是 COVID-19 相关脑炎,通过脑磁共振成像确诊。COVID-19 是一种多系统疾病,有多种并发症,如气胸、气胸、肠系膜缺血、心肌炎和脑炎。通过适当的影像学检查及时确诊可获得适当的治疗和更好的存活率。
{"title":"The Valuable Role of Imaging Modalities in the Diagnosis of the Uncommon Presentations of COVID-19: An Educative Case Series.","authors":"Mohammadreza Khaleghi, Alireza Aziz-Ahari, Nahid Rezaeian, Sanaz Asadian, Amirsajjad Mounesi Sohi, Omid Motamedi, Shilan Azhdeh","doi":"10.1155/2021/7213627","DOIUrl":"10.1155/2021/7213627","url":null,"abstract":"<p><p>The outbreak of coronavirus disease 2019 (COVID-19) in late 2019 rapidly turned into a global pandemic. Although the symptoms of COVID-19 are mainly respiratory ones, the infection is associated with a wide range of clinical signs and symptoms. The main imaging modality in COVID-19 is lung computed tomography (CT) scanning, but the diagnosis of the vast spectrum of complications needs the application of various imaging modalities. Owing to the novelty of the disease and its presentations, its complications-particularly uncommon ones-can be easily missed. In this study, we describe some uncommon presentations of COVID-19 diagnosed by various imaging modalities. The first case presented herein was a man with respiratory distress, who transpired to suffer from pneumothorax and pneumomediastinum in addition to the usual pneumonia of COVID-19. The second patient was a hospitalized COVID-19 case, whose clinical condition suddenly deteriorated with the development of abdominal symptoms diagnosed as mesenteric ischemia by abdominal CT angiography. The third patient was a case of cardiac involvement in the COVID-19 course, detected as myocarditis by cardiac magnetic resonance imaging (MRI). The fourth and fifth cases were COVID-19-associated encephalitis whose diagnoses were established by brain MRI. COVID-19 is a multisystem disorder with a wide range of complications such as pneumothorax, pneumomediastinum, mesenteric ischemia, myocarditis, and encephalitis. Prompt diagnosis with appropriate imaging modalities can lead to adequate treatment and better survival.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"2021 ","pages":"7213627"},"PeriodicalIF":0.8,"publicationDate":"2021-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528572/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39552375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19-Related Pneumonia in an Adolescent Patient with Allergic Asthma. 青少年变应性哮喘患者的covid -19相关肺炎
IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-10-07 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6706218
Öner Özdemir, Muhammet Mesut Nezir Engin, Emine Aylin Yılmaz

Background: The latest coronavirus infection due to SARS-CoV-2, which started in China in December 2019, was announced as a pandemic by the World Health Organization (WHO) in March 2020. All epidemiological data so far show us that SARS-CoV-2 infection is less serious in children than in adults. Allergic asthma, the most common chronic disease in children, is usually not to be related to greater risk or severity for COVID-19 in pediatric populations. Although reports/research on asthma and COVID-19 in children have thus far been comforting, when coming across an asthma patient with any lower airway infection, attention should be given to evaluate their asthma control level and the possibility of SARS-CoV-2 infection. Case Report. Here, we report a rare adolescent case of COVID-19-related pneumonia development with underlying asthma. A 16-year-old male patient has been followed up by the pediatric allergy outpatient clinic with the diagnosis of asthma for the last 5 years. He was thought to have typical clinical and laboratory findings for SARS-CoV-2 infection combined with underlying pediatric (allergic) asthma. Pulmonary CT showed findings consistent with COVID-19-related pneumonia. He was discharged after 1 week when all his complaints regressed, his examination became normal, and 5-day favipiravir treatment was completed.

Conclusion: When a physician comes across an asthma patient with any lower airway infection, attention should be given to evaluate their asthma control level and possibility of SARS-CoV-2 infection.

背景:2019年12月在中国开始的最新冠状病毒感染SARS-CoV-2,于2020年3月被世界卫生组织(WHO)宣布为大流行。到目前为止,所有流行病学数据都表明,儿童感染SARS-CoV-2的严重程度低于成人。过敏性哮喘是儿童中最常见的慢性疾病,通常与儿科人群中COVID-19的高风险或严重程度无关。尽管迄今为止关于儿童哮喘和COVID-19的报告/研究令人欣慰,但当遇到任何下呼吸道感染的哮喘患者时,应注意评估其哮喘控制水平和SARS-CoV-2感染的可能性。病例报告。在这里,我们报告了一例罕见的青少年covid -19相关肺炎发展伴潜在哮喘病例。一名16岁男性患者在儿科过敏门诊随访5年,诊断为哮喘。他被认为具有典型的SARS-CoV-2感染合并潜在儿科(过敏性)哮喘的临床和实验室结果。肺部CT显示符合新冠肺炎相关肺炎。1周后出院,症状消退,检查正常,完成5天favipiravir治疗。结论:当医师遇到有下气道感染的哮喘患者时,应注意评估其哮喘控制水平和SARS-CoV-2感染的可能性。
{"title":"COVID-19-Related Pneumonia in an Adolescent Patient with Allergic Asthma.","authors":"Öner Özdemir,&nbsp;Muhammet Mesut Nezir Engin,&nbsp;Emine Aylin Yılmaz","doi":"10.1155/2021/6706218","DOIUrl":"https://doi.org/10.1155/2021/6706218","url":null,"abstract":"<p><strong>Background: </strong>The latest coronavirus infection due to SARS-CoV-2, which started in China in December 2019, was announced as a pandemic by the World Health Organization (WHO) in March 2020. All epidemiological data so far show us that SARS-CoV-2 infection is less serious in children than in adults. Allergic asthma, the most common chronic disease in children, is usually not to be related to greater risk or severity for COVID-19 in pediatric populations. Although reports/research on asthma and COVID-19 in children have thus far been comforting, when coming across an asthma patient with any lower airway infection, attention should be given to evaluate their asthma control level and the possibility of SARS-CoV-2 infection. <i>Case Report</i>. Here, we report a rare adolescent case of COVID-19-related pneumonia development with underlying asthma. A 16-year-old male patient has been followed up by the pediatric allergy outpatient clinic with the diagnosis of asthma for the last 5 years. He was thought to have typical clinical and laboratory findings for SARS-CoV-2 infection combined with underlying pediatric (allergic) asthma. Pulmonary CT showed findings consistent with COVID-19-related pneumonia. He was discharged after 1 week when all his complaints regressed, his examination became normal, and 5-day favipiravir treatment was completed.</p><p><strong>Conclusion: </strong>When a physician comes across an asthma patient with any lower airway infection, attention should be given to evaluate their asthma control level and possibility of SARS-CoV-2 infection.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"2021 ","pages":"6706218"},"PeriodicalIF":0.8,"publicationDate":"2021-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502245/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39515323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity. 药物性超敏反应继发的Kounis综合征。
IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-10-01 eCollection Date: 2021-01-01 DOI: 10.1155/2021/4485754
Parackrama Karunathilake, Udaya Ralapanawa, Thilak Jayalath, Shamali Abeyagunawardena

Introduction: Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that interact with macrophages and T-lymphocytes, causing degranulation and inflammation with cytokine release. It is a life-threatening condition that has many trigger factors and is most commonly caused by medicines. Case Presentation. A 71-year-old male was admitted with a fever of five days' duration associated with cellulitis, for which he had been treated with clindamycin and flucloxacillin before admission. He was a diagnosed patient with hypertension and dyslipidemia five years ago. After taking the antibiotics, he had developed generalized itching followed by urticaria suggesting an allergic reaction. Therefore, he was admitted to the hospital. After admission, he developed an ischaemic-type chest pain associated with autonomic symptoms and shortness of breath. An immediate ECG was taken that showed ST-segment depressions in the chest leads V4-V6, confirmed by a repeat ECG. Troponin I was 8 ng/mL. Acute management of ACS was started, and prednisolone 10 mg daily dose was given. After complete recovery, the patient was discharged with aspirin, clopidogrel, atorvastatin, metoprolol, losartan, isosorbide mononitrate, and nicorandil. Prednisolone 10 mg daily dose was given for five days after discharge.

Conclusion: In immediate hypersensitivity, with persistent cardiovascular instability, Kounis syndrome should be considered, and an electrocardiogram and other appropriate assessments and treatments should be initiated. Prompt management of the allergic reaction and the ACS is vital for a better outcome of Kounis syndrome.

简介:Kounis综合征是一种急性冠脉综合征(ACS)的并发,在过敏或超敏反应的情况下,由冠状血管痉挛、急性心肌梗死或支架血栓形成引起。Kounis综合征由肥大细胞介导,肥大细胞与巨噬细胞和t淋巴细胞相互作用,引起脱颗粒和炎症,并释放细胞因子。这是一种危及生命的疾病,有许多触发因素,最常见的是由药物引起的。案例演示。1例71岁男性因蜂窝织炎伴发热5天入院,入院前曾用克林霉素和氟氯西林治疗。五年前,他被诊断出患有高血压和血脂异常。服用抗生素后,他出现全身瘙痒,接着出现荨麻疹,表明有过敏反应。因此,他住进了医院。入院后,他出现缺血性胸痛并伴有自主神经症状和呼吸短促。立即进行心电图检查,显示胸部导联V4-V6处st段下降,经重复心电图确认。肌钙蛋白I为8 ng/mL。开始急性ACS治疗,给予强的松龙10mg / d。完全恢复后,患者出院时使用阿司匹林、氯吡格雷、阿托伐他汀、美托洛尔、氯沙坦、单硝酸异山梨酯和尼可地尔。强的松龙每日10mg,出院后5天停用。结论:对于立即过敏并伴有持续心血管不稳定的患者,应考虑Kounis综合征,并应开始心电图和其他适当的评估和治疗。及时处理过敏反应和ACS对于改善Kounis综合征的预后至关重要。
{"title":"Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.","authors":"Parackrama Karunathilake,&nbsp;Udaya Ralapanawa,&nbsp;Thilak Jayalath,&nbsp;Shamali Abeyagunawardena","doi":"10.1155/2021/4485754","DOIUrl":"https://doi.org/10.1155/2021/4485754","url":null,"abstract":"<p><strong>Introduction: </strong>Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that interact with macrophages and T-lymphocytes, causing degranulation and inflammation with cytokine release. It is a life-threatening condition that has many trigger factors and is most commonly caused by medicines. <i>Case Presentation</i>. A 71-year-old male was admitted with a fever of five days' duration associated with cellulitis, for which he had been treated with clindamycin and flucloxacillin before admission. He was a diagnosed patient with hypertension and dyslipidemia five years ago. After taking the antibiotics, he had developed generalized itching followed by urticaria suggesting an allergic reaction. Therefore, he was admitted to the hospital. After admission, he developed an ischaemic-type chest pain associated with autonomic symptoms and shortness of breath. An immediate ECG was taken that showed ST-segment depressions in the chest leads V4-V6, confirmed by a repeat ECG. Troponin I was 8 ng/mL. Acute management of ACS was started, and prednisolone 10 mg daily dose was given. After complete recovery, the patient was discharged with aspirin, clopidogrel, atorvastatin, metoprolol, losartan, isosorbide mononitrate, and nicorandil. Prednisolone 10 mg daily dose was given for five days after discharge.</p><p><strong>Conclusion: </strong>In immediate hypersensitivity, with persistent cardiovascular instability, Kounis syndrome should be considered, and an electrocardiogram and other appropriate assessments and treatments should be initiated. Prompt management of the allergic reaction and the ACS is vital for a better outcome of Kounis syndrome.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"2021 ","pages":"4485754"},"PeriodicalIF":0.8,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39527513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Varicella Zoster Virus Meningitis with Absence of Rash in an Immunocompetent Child. 免疫功能正常儿童无皮疹的水痘带状疱疹病毒性脑膜炎。
IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-09-30 eCollection Date: 2021-01-01 DOI: 10.1155/2021/2081270
Mariam Lagrine, Karima El Fakiri, Noureddine Rada, Ghizlane Draiss, Nabila Soraa, Mohammed Bouskraoui

Only a few cases in the literature have ever reported the reactivation of the varicella zoster virus (VZV) in children especially in the case of immunocompetent patients. It is an uncommon situation that may lead to several neurological complications. We report varicella zoster virus (VZV) meningitis in a 14-year-old healthy boy with no antecedent of rash. On his cerebrospinal fluid (CSF) examination, VZV DNA was detected. The rapid HIV test was negative. The treatment using acyclovir (20 mg/kg/8h) was effective, and the child's clinical condition rapidly improved.

文献中只有少数病例曾报道过水痘带状疱疹病毒(VZV)在儿童中重新激活,特别是在免疫功能正常的患者中。这是一种罕见的情况,可能导致一些神经系统并发症。我们报告水痘带状疱疹病毒(VZV)脑膜炎在14岁的健康男孩没有皮疹的先例。脑脊液(CSF)检查检测到VZV DNA。HIV快速检测呈阴性。阿昔洛韦(20mg /kg/8h)治疗有效,患儿临床病情迅速好转。
{"title":"Varicella Zoster Virus Meningitis with Absence of Rash in an Immunocompetent Child.","authors":"Mariam Lagrine,&nbsp;Karima El Fakiri,&nbsp;Noureddine Rada,&nbsp;Ghizlane Draiss,&nbsp;Nabila Soraa,&nbsp;Mohammed Bouskraoui","doi":"10.1155/2021/2081270","DOIUrl":"https://doi.org/10.1155/2021/2081270","url":null,"abstract":"<p><p>Only a few cases in the literature have ever reported the reactivation of the varicella zoster virus (VZV) in children especially in the case of immunocompetent patients. It is an uncommon situation that may lead to several neurological complications. We report varicella zoster virus (VZV) meningitis in a 14-year-old healthy boy with no antecedent of rash. On his cerebrospinal fluid (CSF) examination, VZV DNA was detected. The rapid HIV test was negative. The treatment using acyclovir (20 mg/kg/8h) was effective, and the child's clinical condition rapidly improved.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"2021 ","pages":"2081270"},"PeriodicalIF":0.8,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497137/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39527512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Emergence Delirium in a 29-Year-Old Man following an Uneventful Appendectomy. 29岁男性阑尾切除术后出现谵妄。
IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-09-25 eCollection Date: 2021-01-01 DOI: 10.1155/2021/1338823
Zhi Wang, Yong Yang, Yang Chen, Kai Lu, Bing Chen

Emergence delirium (ED) is defined as the delirium that occurs during the transition from the sleep state to full consciousness. ED increases the risk for injury, self-extubation, hemorrhages, and prolonged hospitalization and occurs in patients of any age but most often in children and elderly patients. However, ED in young adults is rarely reported. We presented a case of typical ED occurring in a young healthy man following an uneventful appendectomy. The causes of ED can be classified as either predisposing or precipitating factors. In this case, the unnoticeable mental stress may be the predisposing factor and the sevoflurane maintenance of anesthesia may be the precipitating factor. ED occurs at any age of patient and in any minor surgery, and anesthesiologists should do some work to prevent it from happening.

突发性谵妄(ED)是指从睡眠状态过渡到完全意识状态时发生的谵妄。ED增加损伤、自我拔管、出血和住院时间延长的风险,发生在任何年龄的患者中,但最常见于儿童和老年患者。然而,年轻人的ED很少有报道。我们提出了一个典型的ED发生在一个年轻的健康男子后,平安无事的阑尾切除术。ED的病因可分为诱发因素和诱发因素。在这种情况下,不易察觉的精神压力可能是诱发因素,七氟醚维持麻醉可能是诱发因素。ED发生在任何年龄的病人和任何小手术中,麻醉师应该做一些工作来防止它的发生。
{"title":"Emergence Delirium in a 29-Year-Old Man following an Uneventful Appendectomy.","authors":"Zhi Wang,&nbsp;Yong Yang,&nbsp;Yang Chen,&nbsp;Kai Lu,&nbsp;Bing Chen","doi":"10.1155/2021/1338823","DOIUrl":"https://doi.org/10.1155/2021/1338823","url":null,"abstract":"<p><p>Emergence delirium (ED) is defined as the delirium that occurs during the transition from the sleep state to full consciousness. ED increases the risk for injury, self-extubation, hemorrhages, and prolonged hospitalization and occurs in patients of any age but most often in children and elderly patients. However, ED in young adults is rarely reported. We presented a case of typical ED occurring in a young healthy man following an uneventful appendectomy. The causes of ED can be classified as either predisposing or precipitating factors. In this case, the unnoticeable mental stress may be the predisposing factor and the sevoflurane maintenance of anesthesia may be the precipitating factor. ED occurs at any age of patient and in any minor surgery, and anesthesiologists should do some work to prevent it from happening.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"2021 ","pages":"1338823"},"PeriodicalIF":0.8,"publicationDate":"2021-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39485440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diagnosis and Management of Acquired Hemophilia A: Case Reports and a Literature Review. 获得性血友病A的诊断和治疗:病例报告和文献综述。
IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-09-14 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5554664
Ikhwan Rinaldi, Findy Prasetyawaty, Siti Fazlines, Kevin Winston, Yusuf Aji Samudera Nurrobi, Jessica Leoni, Ilham Hidayat Restu Tulus Maha, Satrio Wicaksono, Abdillah Yasir Wicaksono, Averina Octaxena Aslani, Rizkania Ikhsani

Background: Acquired hemophilia A (AHA) is a potentially life-threatening autoimmune hemostatic disorder where autoantibodies that disrupt the functions of factor VIII (FVIII) are present in the circulation. The early diagnosis of AHA is difficult since the symptoms of AHA differ from those of congenital hemophilia A. Furthermore, the management of AHA is also more complex due to the presence of autoantibodies against FVIII (FVIII inhibitors). Here, we present three case reports and conduct a literature review of AHA with the aim to increase awareness and knowledge regarding the diagnosis and treatment of AHA. Case Presentations. We present three patients diagnosed with AHA in these case reports. The first patient was a young female, while the second and third patients were middle-aged and elderly males, respectively. All patients presented with a chief complaint of bruises without hemarthrosis and a history of bleeding. Laboratory examinations of the patients revealed isolated prolonged aPTT, normal PT, and the presence of autoantibodies against factor VIII, which are characteristics of AHA. Patients were then treated with corticosteroids to reduce the titer level of autoantibodies and received factor VIII transfusion to stop bleeding.

Conclusion: AHA can be suspected in patients presenting with symptoms of bruises without hemarthrosis and without the history of bleeding. Isolated aPTT elevation with normal PT should raise high suspicion of AHA. The presence of FVIII inhibitors can help to confirm the diagnosis of AHA. Treatment consists of factor VIII transfusion and corticosteroid therapy. Bypassing agents are recommended as an alternative to FVIII transfusion.

背景:获得性血友病A (AHA)是一种潜在危及生命的自身免疫性止血疾病,其血液循环中存在破坏因子VIII (FVIII)功能的自身抗体。AHA的早期诊断是困难的,因为AHA的症状不同于先天性a型血友病。此外,由于存在针对FVIII (FVIII抑制剂)的自身抗体,AHA的治疗也更为复杂。在这里,我们提出三个病例报告,并进行文献综述,目的是提高对AHA诊断和治疗的认识和知识。例演示。我们在这些病例报告中提出了三例诊断为AHA的患者。第一位患者为年轻女性,第二位和第三位患者分别为中老年男性。所有患者均以无关节积血和出血史的瘀伤为主诉。患者的实验室检查显示分离的aPTT延长,PT正常,存在抗因子VIII自身抗体,这些都是AHA的特征。患者随后接受皮质类固醇治疗以降低自身抗体滴度,并接受因子VIII输血以止血。结论:出现瘀伤症状而无关节积血和无出血史的患者可怀疑AHA。单独aPTT升高而PT正常应引起对AHA的高度怀疑。FVIII抑制剂的存在有助于确认AHA的诊断。治疗包括因子VIII输注和皮质类固醇治疗。建议使用旁路剂替代FVIII输液。
{"title":"Diagnosis and Management of Acquired Hemophilia A: Case Reports and a Literature Review.","authors":"Ikhwan Rinaldi,&nbsp;Findy Prasetyawaty,&nbsp;Siti Fazlines,&nbsp;Kevin Winston,&nbsp;Yusuf Aji Samudera Nurrobi,&nbsp;Jessica Leoni,&nbsp;Ilham Hidayat Restu Tulus Maha,&nbsp;Satrio Wicaksono,&nbsp;Abdillah Yasir Wicaksono,&nbsp;Averina Octaxena Aslani,&nbsp;Rizkania Ikhsani","doi":"10.1155/2021/5554664","DOIUrl":"https://doi.org/10.1155/2021/5554664","url":null,"abstract":"<p><strong>Background: </strong>Acquired hemophilia A (AHA) is a potentially life-threatening autoimmune hemostatic disorder where autoantibodies that disrupt the functions of factor VIII (FVIII) are present in the circulation. The early diagnosis of AHA is difficult since the symptoms of AHA differ from those of congenital hemophilia A. Furthermore, the management of AHA is also more complex due to the presence of autoantibodies against FVIII (FVIII inhibitors). Here, we present three case reports and conduct a literature review of AHA with the aim to increase awareness and knowledge regarding the diagnosis and treatment of AHA. <i>Case Presentations</i>. We present three patients diagnosed with AHA in these case reports. The first patient was a young female, while the second and third patients were middle-aged and elderly males, respectively. All patients presented with a chief complaint of bruises without hemarthrosis and a history of bleeding. Laboratory examinations of the patients revealed isolated prolonged aPTT, normal PT, and the presence of autoantibodies against factor VIII, which are characteristics of AHA. Patients were then treated with corticosteroids to reduce the titer level of autoantibodies and received factor VIII transfusion to stop bleeding.</p><p><strong>Conclusion: </strong>AHA can be suspected in patients presenting with symptoms of bruises without hemarthrosis and without the history of bleeding. Isolated aPTT elevation with normal PT should raise high suspicion of AHA. The presence of FVIII inhibitors can help to confirm the diagnosis of AHA. Treatment consists of factor VIII transfusion and corticosteroid therapy. Bypassing agents are recommended as an alternative to FVIII transfusion.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"2021 ","pages":"5554664"},"PeriodicalIF":0.8,"publicationDate":"2021-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457949/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39452076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Primary Retroperitoneal Malignant Melanoma with Involvement of Iliac Artery and Vein. 累及髂动静脉的原发性腹膜后恶性黑色素瘤。
IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-09-04 eCollection Date: 2021-01-01 DOI: 10.1155/2021/3526071
Aislyn Oulee, Ling Xu, Scott Worswick

Primary retroperitoneal melanoma is a very rare extracutaneous presentation of melanoma. In this case report, we present a 65-year-old female with unilateral lower extremity edema secondary to occlusion of iliac vessels by a primary retroperitoneal melanoma tumor. We also review the findings in other cases previously described in the literature.

原发性腹膜后黑色素瘤是一种非常罕见的皮肤外黑色素瘤。在这个病例报告中,我们提出了一个65岁的女性单侧下肢水肿继发于原发性腹膜后黑色素瘤阻塞髂血管。我们也回顾了先前文献中描述的其他病例的发现。
{"title":"Primary Retroperitoneal Malignant Melanoma with Involvement of Iliac Artery and Vein.","authors":"Aislyn Oulee,&nbsp;Ling Xu,&nbsp;Scott Worswick","doi":"10.1155/2021/3526071","DOIUrl":"https://doi.org/10.1155/2021/3526071","url":null,"abstract":"<p><p>Primary retroperitoneal melanoma is a very rare extracutaneous presentation of melanoma. In this case report, we present a 65-year-old female with unilateral lower extremity edema secondary to occlusion of iliac vessels by a primary retroperitoneal melanoma tumor. We also review the findings in other cases previously described in the literature.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"2021 ","pages":"3526071"},"PeriodicalIF":0.8,"publicationDate":"2021-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Case Reports in Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1